Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Drug-AZD8931|DRUG: Drug-Placebo
Sponsor: AstraZeneca